Philippines - English - FDA (Food And Drug Administration)

united douglas pharm philippines inc - multivitamins , minerals , herbs - soft capsule - each soft gel capsule contains: retinol acetate (vitamin a)-5,000i.u. ergocalciferol (vitamin d2)-400i.u ascorbic acid (vitamin c)-60.00mg tocopherol acetate (vitamin e)-45.00mg nicotinamide (vitamin b3)-20.00mg calcium pantothenate (vitamin b5)-15.30mg thiamine nitrate (vitamin b1)-2.00mg riboflavin (vitamin b2) -2.00mg . pyridoxin hydrochloride (vitamin b6)-2.00mg cyanocobalamin (vitamin b12)-6mcg magnesium-66.34mg iron (equivalent to 54.76mg ferrous fumarate)-18mg zinc (equivalent to 5mg zinc oxide)-4.00mg copper (equivalent to 7.86mg cupric sulfate)-2.00mg panax ginseng c.a. meyer (fam. araliaceae) roots-40.00mg aloe ferox miller (asphodelaceae) leaves -5.00mg

United States - English - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - zinc acetate (unii: fm5526k07a) (zinc cation - unii:13s1s8sf37) - zinc cation 25 mg - zinc acetate therapy is indicated for maintenance treatment of patients with wilson’s disease who have been initially treated with a chelating agent (see precautions: monitoring patients). zinc acetate capsules are contraindicated in patients with known hypersensitivity to any of the components of the formulation.

United States - English - NLM (National Library of Medicine)

united douglas pharm., inc. - aceclofenac (unii: rpk779r03h) (aceclofenac - unii:rpk779r03h) - aceclofenac 200 mg - indications clanza cr is indicated for rheumatoid arthritis, ankylosing spondylitis, osteoarthritis and periarthritis of scapulohumerous, lumbago, ischiadynia, pain caused by nonaticular rheutism. contraindications patients with allergy to these drugs or other analogues (diclofenac). patients with asthma. like nsaids, acetylsalicylic acid and other drugs which inhibit prostagladin-synthesis may precipitate attacks of asthma, acute rhinitis or urticaria. patients with active peptic ulcer. use in children the dosage and indication is not established yet for children with less than 6 years old.

United States - English - NLM (National Library of Medicine)

united douglas pharm., inc. - potassium iodide (unii: 1c4qk22f9j) (iodine - unii:9679tc07x4) - potassium iodide 130 mg - purpose   ---   thyroid blocking use   ---  potassium iodide helps prevent radioactive iodine from getting into the thyroid gland during a nuclear radiation emergency.  use along with other emergency measures recommended by public officials.

United States - English - NLM (National Library of Medicine)

laboratoire aguettant - zinc gluconate trihydrate (unii: f2f0xu34wq) (zinc cation - unii:13s1s8sf37) - zinc cation 1 mg in 1 ml

United States - English - NLM (National Library of Medicine)

hameln pharma gmbh - pentetate zinc trisodium (unii: nxu65ic8pg) (pentetic acid - unii:7a314hqm0i) - pentetate zinc trisodium 1000 mg in 5 ml - zn-dtpa is indicated for treatment of individuals with known or suspected internal contamination with plutonium, americium, or curium to increase the rates of elimination. none. pregnancy category b risk summary there are no adequate and well-controlled studies of zn-dtpa use in pregnant women. chelation treatment of pregnant women should begin and continue with zn-dtpa. reproduction studies have been performed in pregnant mice at doses up to 31 times (11.5 mmol/kg) the recommended daily human dose and have revealed no evidence of impaired fertility or harm to the fetus due to zn-dtpa. there was a slight reduction in the average birth weight. because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. it is not known whether zn-dtpa is excreted in human milk. radiocontaminants are known to be excreted in breast milk. women with known or suspected internal contamination with radiocontaminants should not breast feed, whether

United States - English - NLM (National Library of Medicine)

united natural foods, inc. - tetrahydrozoline hydrochloride (unii: 0yzt43hs7d) (tetrahydrozoline - unii:s9u025y077), zinc sulfate (unii: 89ds0h96tb) (zinc cation - unii:13s1s8sf37) - purposes tetrahydrozoline hcl......redness reliever zinc sulfate......astringent use - for temporary relief of discomfort and redness of the eye due to minor eye irritation

Ireland - English - HPRA (Health Products Regulatory Authority)

ayrton saunders ltd - zinc oxide; dimeticone 350 - cutaneous spray, solution - 12.5%w/w + 1.04 percent weight/weight - zinc products

United States - English - NLM (National Library of Medicine)

keltman pharmaceuticals inc. - sertraline hydrochloride (unii: uti8907y6x) (sertraline - unii:quc7nx6wmb) - sertraline hydrochloride 50 mg - major depressive disorder – sertraline hydrochloride is indicated for the treatment of major depressive disorder in adults. the efficacy of sertraline hydrochloride in the treatment of a major depressive episode was established in six to eight week controlled trials of adult outpatients whose diagnoses corresponded most closely to the dsm-iii category of major depressive disorder (see clinical trials under clinical pharmacology). a major depressive episode implies a prominent and relatively persistent depressed or dysphoric mood that usually interferes with daily functioning (nearly every day for at least 2 weeks); it should include at least 4 of the following 8 symptoms: change in appetite, change in sleep, psychomotor agitation or retardation, loss of interest in usual activities or decrease in sexual drive, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, and a suicide attempt or suicidal ideation. the antidepressant action of sertraline hydrochloride in hos

United States - English - NLM (National Library of Medicine)

keltman pharmaceuticals inc. - ketorolac tromethamine (unii: 4eve5946bq) (ketorolac tromethamine - unii:4eve5946bq) - ketorolac tromethamine 10 mg - carefully consider the potential benefits and risks of ketorolac tromethamine and other treatment options before deciding to use ketorolac tromethamine. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals. ketorolac tromethamine tablets are indicated for the short-term (≤ 5 days) management of moderately severe acute pain that requires analgesia at the opioid level, usually in a postoperative setting. therapy should always be initiated with iv or im dosing of ketorolac tromethamine, and ketorolac tromethamine tablets are to be used only as continuation treatment, if necessary. the total combined duration of use of ketorolac tromethamine tablets and ketorolac tromethamine is not to exceed 5 days of use because of the potential of increasing the frequency and severity of adverse reactions associated with the recommended doses (see warnings , precautions , dosage and administration , and adverse reactions ). patients should be switched to alternative analges